AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Amylyx Pharmaceuticals, Inc.

$28.86 +$17.44 (+152.71%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$28.68
Day Range
$28.00$29.09
Year Range
$10.83$41.14
Market Cap
3.62B
AVG Volume
2.11M
Trailing/Forward PE
-20.47/-
PEG ratio
5.75
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
-100M0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AMLX Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q20
26 Q10
25 Q40
25 Q3-665K
25 Q2-249K
25 Q1-1.27M
24 Q487.37M
24 Q3196.49M
24 Q2298.76M
24 Q1398M
Net Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AMLX Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-152.09M
26 Q1-150.11M
25 Q4-144.74M
25 Q3-149.28M
25 Q2-187.6M
25 Q1-218.86M
24 Q4-301.74M
24 Q3-259.47M
24 Q2-165.87M
24 Q1-71.09M
Operating Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AMLX Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-162.1M
26 Q1-159.27M
25 Q4-153.29M
25 Q3-157.34M
25 Q2-196.97M
25 Q1-207.55M
24 Q4-291.88M
24 Q3-249.29M
24 Q2-154.91M
24 Q1-81.28M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: AMLX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Amylyx Pharmaceuticals, Inc.
AMLX
Stockpicker

Video analysis: AMLX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AMLX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.